Risperdal Leads
Reach males who developed gynecomastia (abnormal breast growth) and other hormonal disorders after taking the antipsychotic medication Risperdal (risperidone).
Risperdal Litigation
Risperdal (risperidone), manufactured by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, is an antipsychotic medication prescribed for schizophrenia, bipolar disorder, and irritability associated with autism. The drug has been linked to gynecomastia, a condition causing abnormal breast tissue growth in males, particularly in boys and young men. Juries have awarded billions in damages, finding that Janssen failed to adequately warn about the risk of gynecomastia and illegally marketed the drug for off-label use in children.
Associated Conditions
- Gynecomastia (abnormal breast growth in males)
- Breast tissue enlargement requiring surgical intervention
- Hormonal disorders and elevated prolactin levels
- Galactorrhea (abnormal breast milk production)
- Psychological distress and emotional harm
- Sexual dysfunction
- Weight gain and metabolic disorders
Claimant Eligibility
- Prescribed Risperdal (risperidone) and developed gynecomastia
- Male patients, particularly boys or young men prescribed the medication
- Experienced abnormal breast tissue growth during or after Risperdal use
- Required surgery (mastectomy) to correct gynecomastia
- Medical records confirming Risperdal prescription and diagnosis
Why Law Firms Choose Us
Exclusive Leads
Every lead is yours alone. We never resell or share claimant information with competing firms, guaranteeing you first-mover advantage on every case.
Pre-Qualified Claimants
Our intake specialists screen every potential claimant against your specific case criteria before delivery, so your team only speaks with viable cases.
Live Transfer
Qualified claimants are transferred directly to your intake team in real time, maximizing conversion rates and reducing time-to-retainer.
Running a Risperdal mass tort marketing campaign
Common questions from law firms about Risperdal lead generation and campaign management.
- What does a Risperdal mass tort marketing campaign include?
- A Risperdal mass tort marketing campaign from Mass Tort Marketing Agency covers channel strategy across Meta, Google/PPC, OTT, and mass tort SEO; compliant ad creative; TCPA-verified intake; claimant qualification against your Risperdal case criteria; and signed-retainer reporting. Performance is measured on cost per signed retainer, not raw lead volume.
- Are Risperdal leads exclusive to my firm?
- Yes. Every Risperdal lead is delivered to one firm only — never resold, syndicated, or shared with competing firms. Your firm owns the contact data, consent records, and call recordings.
- How are Risperdal claimants qualified before delivery?
- Each Risperdal claimant is screened against tort-specific facts (exposure windows, injury markers, and state eligibility) and carries a TrustedForm or Jornaya consent token captured under the FCC one-to-one consent standard before the lead reaches your intake team.
- How is a Risperdal campaign priced?
- Campaigns are quoted and reported on cost per signed retainer (CPSR), so spend ties directly to signed cases rather than lead count. You can scale volume up or down by tort as your docket capacity changes.
See how every lead is qualified on our mass tort leads page, or compare providers in our top mass tort marketing firms guide.